Transpara vs DeepHealth (formerly Kheiron Medical Technologies)

Direct competitors — feature-level head-to-head below. Comparability 95/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Transpara

by ScreenPoint Medical

DeepHealth (formerly Kheiron Medical Technologies)

by DeepHealth (formerly Kheiron Medical Technologies)

AI Verdict

Transpara and DeepHealth (Mia) are highly comparable, both offering FDA-cleared AI solutions for breast cancer detection in mammography to enhance radiologist workflow. While Transpara emphasizes 2D and 3D mammogram analysis with features like temporal comparison and breast density assessment, DeepHealth highlights its role as an independent or concurrent reader and a triage tool for breast screening. Both aim to improve diagnostic accuracy and workflow efficiency within radiology practices.

Choose Transpara if…

Choose Transpara if your primary focus is on leveraging advanced AI for comprehensive breast cancer detection across both 2D and 3D mammography, including temporal comparisons and detailed risk categorization. This tool is ideal for practices seeking to optimize radiologist workflow with features like concurrent reading aid and high negative predictive value for low-risk cases, especially within existing PACS and DICOM pipelines or through cloud-enabled access via Microsoft for Healthcare.

View Transpara →

Choose DeepHealth (formerly Kheiron Medical Technologies) if…

Choose DeepHealth's Mia if your organization requires a flexible, cloud-native AI solution for breast cancer detection that can also function as an independent reader or a triage tool for large-scale breast screening programs. This tool is well-suited for practices prioritizing enhanced workflow efficiency and improved diagnostic accuracy with seamless integration into various deployment environments, including AWS Marketplace and on-premise setups.

View DeepHealth (formerly Kheiron Medical Technologies) →

When choosing between Transpara and DeepHealth’s Mia for breast imaging AI, physicians should consider their primary workflow needs and desired level of AI integration. Transpara, from ScreenPoint Medical, excels in providing comprehensive AI support for both 2D and 3D mammography, offering features like temporal comparison across multiple prior studies and detailed breast density assessment. Its strength lies in its ability to provide region-based and overall exam scores, coupled with risk categorization, which can significantly aid in concurrent reading and workflow optimization for radiologists. Transpara is best suited for practices seeking a robust AI assistant that offers in-depth analysis and historical comparison capabilities to enhance detection and streamline the reading process.

DeepHealth’s Mia, on the other hand, emphasizes flexibility in its deployment and operational role. While also focused on enhancing breast cancer detection and workflow efficiency, Mia distinguishes itself by functioning both as an independent reader and a concurrent reader, as well as a triage tool for breast screening. This key practical difference means Mia can be adapted to various screening program models, potentially reducing radiologist workload by independently reviewing a subset of cases. Physicians looking for an AI solution that can act as a primary independent reader or a flexible triage tool within large-scale diagnostic and screening programs may find Mia to be a more suitable choice, especially given its cloud-native deployment options.

Quick Comparison

Feature	Transpara	DeepHealth (formerly Kheiron Medical Technologies)
Deployment	Transpara integrates into PACS and reading workflows via medical-imaging (DICOM) pipelines. It is also available through Precision Imaging Network, part of Microsoft for Healthcare, which simplifies deployment pathways for cloud-enabled access within existing clinical ecosystems.	Cloud-native (DeepHealth OS), AWS Marketplace, on-premise (interoperable with legacy PACS).
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Transpara

Transpara emphasizes an intuitive, mobile-ready interface that can be used by various stakeholders without coding expertise, suggesting a strong focus on user experience. DeepHealth also aims for intuitive technology and seamless integration, but Transpara's explicit mention of a 'mobile-ready interface' and 'no coding expertise' gives it a slight edge in stated usability.

Clinical Value

Transpara

Transpara has a robust body of clinical evidence, including being the first breast AI solution validated by a randomized controlled trial (MASAI study), showing a 29% increase in cancer detection and a 44% workload reduction. DeepHealth also has strong clinical validation, with studies showing improved cancer detection rates and general radiologists achieving specialist-level performance with their AI-powered workflow. However, Transpara's extensive peer-reviewed publications (over 55 as of late 2025) and the landmark MASAI trial provide a slightly stronger and more widely cited clinical backing.

Pricing & Value

Tie

Neither Transpara nor DeepHealth provide specific pricing details in the provided information or readily available online. Transpara states that all software and updates are included in their license packages and subscription plans, and they offer a free 30-day trial. DeepHealth's parent company, RadNet, has an 'Enhanced Breast Cancer Detection program' that charges women $40 to have AI read their mammograms, which gives some insight into their value proposition but not overall product pricing. Without transparent pricing for the enterprise solutions, it's difficult to determine a clear winner in this dimension.

Enterprise Readiness

Transpara

Transpara integrates into PACS and reading workflows via DICOM pipelines and is available through Microsoft for Healthcare's Precision Imaging Network, simplifying cloud-enabled access. It also supports cloud, on-premise, and hybrid deployments. DeepHealth offers cloud-native, AWS Marketplace, and on-premise deployments, and is HIPAA compliant with a BAA. While both offer flexible deployment, Transpara's integration with a major healthcare platform like Microsoft for Healthcare and its stated use by leading hospitals and health systems in over 200 clinics across 25+ countries demonstrates a slightly broader and more established enterprise footprint.

Innovation

Transpara

Transpara offers unique features such as Temporal Comparison, which analyzes current studies against up to three prior exams over six years, and advanced breast density assessment (BI-RADS-like and volumetric). DeepHealth also has innovative features like an AI-powered breast ultrasound tool that detects, characterizes lesions, and generates radiology reports, and Breast Arterial Calcification (BAC) Assessment. However, Transpara's Temporal Comparison, which leverages historical data in a sophisticated way for improved detection and specificity, appears to be a particularly notable innovation in the mammography AI space.

Support & Docs

Transpara

Transpara explicitly mentions 'Proactive Support' as a passion, including remote training and direct assistance via web meetings with engineers, and frequent software updates (about every 10 days) with new features included at no extra cost for subscription plans. DeepHealth's information does not detail its support and documentation offerings as extensively. Transpara's clear commitment to proactive support and continuous updates gives it an advantage in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Transpara	DeepHealth (formerly Kheiron Medical Technologies)
Product Name	Transpara	Mia (now part of DeepHealth's SmartMammo™ Breast Suite)
Company	ScreenPoint Medical	DeepHealth (formerly Kheiron Medical Technologies)
API Available	yes	1
Key Features (Breast Cancer Detection)	AI-powered detection for 2D and 3D mammograms (FFDM and DBT); Temporal Comparison (analyzes current study against up to 3 priors over 6 years); Breast Density assessment (BI-RADS-like and volumetric); Risk categorization (Elevated, Intermediate, Low); Region-based and overall exam scores; High negative predictive value for low-risk cases (99.97%)	AI-powered breast cancer detection; Functions as independent reader; Functions as concurrent reader; Triage tool for breast screening; Improved diagnostic accuracy
Key Features (Workflow Optimization)	Workflow optimization and workload reduction; Concurrent reading aid for radiologists	Enhanced workflow efficiency; Seamless integration into existing workflows; Supports radiologists in decision-making
Customer Count	Deployed in over 30 countries and has been used to analyze over 13 million mammograms worldwide. In 2025, it surpassed 11 million mammograms processed. As of September 2022, it had helped radiologists read over three million mammograms. In May 2023, over 4 million mammograms had been analyzed. It is used in over 200 clinics in 25+ countries.	Over 2,890 customers worldwide.
Headquarters	Nijmegen, Netherlands	Somerville, MA, USA (DeepHealth). Kheiron Medical Technologies was headquartered in London, UK.
Founded Year	2014	2015

Videos

Demos, reviews, and walkthroughs featuring Transpara and DeepHealth (formerly Kheiron Medical Technologies).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing radiology workflows and EHR systems?

Transpara integrates into PACS and reading workflows via medical-imaging (DICOM) pipelines and is also available through the Precision Imaging Network, part of Microsoft for Healthcare, for cloud-enabled access within existing clinical ecosystems. DeepHealth's Mia, now part of the SmartMammo™ Breast Suite, is designed for seamless integration into existing diagnostic workflows and technology, and DeepHealth OS is a cloud-native foundation intended to unify clinical and operational data across the imaging experience.

What are the key differences in accuracy and sensitivity for breast cancer detection?

Transpara has demonstrated improved sensitivity with AI support (86% vs 81%) without increasing reading time or affecting specificity in 3D mammograms. It has also been shown to reduce false positives by 25.1% and radiologist workload by over 60% in some screening programs. DeepHealth's AI-powered breast ultrasound platform has shown over 98% accuracy in localizing breast lesions, an 8% increase in overall cancer detection sensitivity, and a 37% reduction in radiologist interpretation time.

How do these tools support different breast imaging specialties and clinical contexts?

Transpara is designed for 2D and 3D mammography, offering features like temporal comparison (analyzing current against up to three prior studies over six years), breast density assessment (BI-RADS-like and volumetric), and risk categorization. DeepHealth's Breast Suite includes AI-powered cancer detection for mammography and ultrasound, automated density assessment, breast arterial calcification assessment, and risk prediction, aiming to standardize breast cancer care across screening and diagnostic workflows.

What is the typical learning curve for radiologists using these AI tools?

Transpara is designed to work concurrently with radiologists, providing a risk-based analysis and highlighting areas of concern to help radiologists focus. Users have reported that the product fits seamlessly into their workflow and has increased mammography workflow over time. DeepHealth aims for a human-centered, intuitive technology, with its platform bringing lesion detection, feature characterization, and draft report generation into a single workspace to standardize care.

What kind of customer support and training are available for these solutions?

Transpara offers customer support via phone and email, and encourages web meetings for live assistance and screen sharing. DeepHealth emphasizes its commitment to commercializing leading-edge radiology solutions and aims to provide an integrated radiology workflow.

What audit-trail features are available to track AI-assisted interpretations?

While specific audit-trail features are not detailed for DeepHealth, Transpara provides region-based and overall exam scores, along with risk categorization (Elevated, Intermediate, Low), which can contribute to an auditable record of AI's input on a case.

How do these tools facilitate multi-site rollouts and ensure consistent performance across different locations?

Transpara is deployed in over 30 countries and has analyzed over 13 million mammograms worldwide, suggesting its capability for large-scale implementation and consistent performance. DeepHealth OS is a modular, secure, and scalable cloud-native operating system designed to create personalized AI-powered workspaces for teams across the radiology workflow, facilitating integration with existing hardware and software systems for diverse customer settings.